References
- FongDSAielloLPFerrisFLIIIKleinRDiabetic retinopathyDiabetes Care2004272540255315451934
- SinghRRamasamyKAbrahamCGuptaVGuptaADiabetic retinopathy: an updateIndian J Ophthalmol20085617818818417817
- PerumalsamyNPrasadNMSathyaSRamasamyKSoftware for reading and grading diabetic retinopathy: Aravind Diabetic Retinopathy Screening 3.0Diabetes Care2007302302230617507695
- AkdumanLOlkRJThe early treatment for diabetic retinopathyKertsCClinical Trials in Ophthalmology – A Summary and Practice Guide3rd edPhiladelphia, PALippincott1998
- AielloLMCavalleranoJDAielloLPBursellSEDiabetic retinopathyGuyerDRYannuzziLAChangSRetina Vitreous Macula6th edPhiladelphia, PASaunders1999
- TervaertTWMooyaartALAmannKPathologic classification of diabetic nephropathyJ Am Soc Nephrol20102155656320167701
- RandLIPrud’hommeGJEdererFCannerPLFactors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10Invest Ophthalmol Vis Sci1985269839912409053
- FongDSSegalPPMyersFFerrisFLHubbardLDDavisMDSubretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research GroupArch Ophthalmol19971158738779230827
- The Diabetic Retinopathy Vitrectomy Study Research GroupEarly vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5Arch Ophthalmol19901089589642196036
- The DCCT Research GroupHypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research GroupDiabetes1997462712869000705
- UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupLancet19983528378539742976
- Early Treatment Diabetic Retinopathy Study Research GroupGrading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1991987868062062513
- Early Treatment Diabetic Retinopathy Study Research GroupFundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology1991988238332062515
- GarziaRBorstingENicholsonSPressLScheimanMSolanHOptometric Clinical Practice Guideline: Care of the Patient with Learning Related Vision Problems: Reference Guide for CliniciansSt Louis, MOAmerican Optometric Association2006
- LiesegangTJSkutaGLCantorLBRetina and Vitreous25th edSan Francisco, CALEO Publication2004
- FrankRNPotential new medical therapies for diabetic retinopathy: protein kinase C inhibitorsAm J Ophthalmol200213369369811992868
- BhavsarARDiabetic retinopathy: the latest in current managementRetina200626S71S7916832305
- FedermanJLGourasPSchubertHDSystemic diseasesPodosSMYanoffMRetina and Vitreous – Textbook of Ophthalmology24th edNew York, NYMcGraw Hill1994
- PardiantoGUnderstanding Diabetic Retinopathy in Mimbar Ilmiah Oftalmologi Indonesia2005
- FrankRNEtiologic mechanisms in diabetic retinopathyRyanSJRetina2nd edPhiladelphia, PALippincott1994
- MurataTNakagawaKKhalilAIshibashiTInomataHSueishiKThe relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinasLab Invest1996748198258606491
- LevyAPLevyNSWegnerSGoldbergMATranscriptional regulation of the rat vascular endothelial growth factor gene by hypoxiaJ Biol Chem199527013333133407768934
- BattegayEJAngiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJ Mol Med (Berl)1995733333468520966
- ResnickHEHarrisMIBrockDBHarrisTBAmerican Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination SurveyDiabetes Care20002317610868827
- FunatsuHYamashitaHNakanishiYHoriSAngiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyBr J Ophthalmol20028631131511864890
- HernandezCBurgosRCantonAGarcia-ArumiJSeguraRMSimoRVitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control studyDiabetes Care20012451652111289478
- MalikRALiCAzizWElevated plasma CD105 and vitreous VEGF levels in diabetic retinopathyJ Cell Mol Med2005969269716202216
- HernandezCLecubeASeguraRMSararolsLSimoRNitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathyDiabet Med20021965566012147146
- SimoRLecubeASeguraRMGarciaAJHernandezCFree insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyAm J Ophthalmol200213437638212208249
- WatanabeDSuzumaKSuzumaIVitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathyAm J Ophthalmol200513947648115767056
- SydorovaMLeeMSVascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathyOphthalmic Res20053718819015990461
- Hogeboom van BuggenumIMPolakBCReichert-ThoenJWde Vries-KnoppertWAvan HinsberghVWTangelderGJAngiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathyDiabetologia20024520320911935151
- AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
- DengJWuDZGaoRElevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyYan Ke Xue Bao199915172112579655
- AmbatiJChalamKVChawlaDKElevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyArch Ophthalmol1997115116111669298058
- ZhouHZhangHA comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathyZhonghua Yan Ke Za Zhi199733247250 Chinese10451953
- AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol19941184454507943121
- BurgosRSimoRAudiLVitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathyDiabetologia199740110711099300249
- ShinodaKIshidaSKawashimaSClinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathyCurr Eye Res20002165566111148602